Please use this identifier to cite or link to this item:
https://biore.bio.bg.ac.rs/handle/123456789/6483
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Čvoro, A. | en_US |
dc.contributor.author | Sieglaff, D.H. | en_US |
dc.contributor.author | Jones, P. | en_US |
dc.contributor.author | Pownall, H.J. | en_US |
dc.date.accessioned | 2023-11-09T12:05:10Z | - |
dc.date.available | 2023-11-09T12:05:10Z | - |
dc.date.issued | 2019 | - |
dc.identifier.uri | https://biore.bio.bg.ac.rs/handle/123456789/6483 | - |
dc.description | p66 | en_US |
dc.title | TLX/NR2E1 – a Promising Therapeutic Target for Brain Tumors: Understanding Differences between Liganded and Unliganded TLX Actions | en_US |
dc.type | Conference Paper | en_US |
dc.relation.conference | 3 rd Exploring DNA Repair Pathways as Targets for Cancer Therapy Conference. Nassau, Bahamas | en_US |
dc.description.rank | M34 | en_US |
item.cerifentitytype | Publications | - |
item.openairetype | Conference Paper | - |
item.fulltext | No Fulltext | - |
item.grantfulltext | none | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
crisitem.author.dept | Chair of Cell and Tissue Biology | - |
crisitem.author.orcid | 0009-0007-5643-1634 | - |
Appears in Collections: | Conference abstract |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.